AV
Avacta Group Plc
AVCTF · OTC
$0.97 +1.57% (+$0.02)
1M +7.78%
Market Cap £336.5M
P/E Ratio -
Div. Yield -
ROE 255.53%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 135.94x
P/S 2,978.60x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 48.79%
Rev. growth 77.30%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 26,756.80%
Gross margin 1,031.86%
FCF margin 21,950.60%
Quality
0 /100
Poor ROA 130.46%
ROIC 172.01%
Asset turnover 0.00x
Debt
7 /100
High Int. coverage -4.29x
Debt/Equity 6.02x
Current ratio 0.89x
Stability
19 /100
Unstable EPS volatility 65.94%
Beta -0.10x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVCTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christina Marie Coughlin
Employees
154
Headquarters
London
Upcoming events
05 OCT
Earnings
Upcoming earnings report